Historically, ACIP has been one of the most transparent federal committees, they wrote, with rigorous reporting on conflicts ...

In today's Pharmalittle roundup, we're reading about a Lilly deal, a gene therapy shock for Duchenne families, and more.

Eli Lilly said Tuesday that it will acquire Verve Therapeutics, a biotech developing gene-editing therapies for cardiovascular disease.

As Isomorphic Labs aims its artificial intelligence tools at drug development, it’s setting up a new outpost in the biotech ...

China is a one of the most important regions for the booming obesity market, thanks to government incentives and changing ...

AI developer Nabla has raised $70 million as the company looks to expand the capabilities of its software that automates ...

Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.

Christopher Gregg has lived years beyond what his oncologists originally accepted. Lessons from farming may have helped.

Humana leaders asserted at the company’s investor day Monday that there’s still money to be made on Medicare Advantage ...

WASHINGTON — To help pay for President Trump’s tax cuts, the Senate is clamping down on tactics that states use to boost ...

Health care proposals in the One Big Beautiful Bill Act could lead to more than 16,000 preventable deaths, a new analysis ...

All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying “destabilizing ...